Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

379 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin.
Wobser M, Keikavoussi P, Kunzmann V, Weininger M, Andersen MH, Becker JC. Wobser M, et al. Among authors: andersen mh. Cancer Immunol Immunother. 2006 Oct;55(10):1294-8. doi: 10.1007/s00262-005-0102-x. Epub 2005 Nov 29. Cancer Immunol Immunother. 2006. PMID: 16315030 Free PMC article. Clinical Trial.
HLA-A2-restricted survivin-derived T-cell responses.
Straten PT, Andersen MH. Straten PT, et al. Among authors: andersen mh. Vaccine. 2011 Dec 6;29(52):9582. doi: 10.1016/j.vaccine.2011.04.085. Epub 2011 May 11. Vaccine. 2011. PMID: 21569816 No abstract available.
Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopes.
Eggert AO, Andersen MH, Voigt H, Schrama D, Kämpgen E, Straten PT, Becker JC. Eggert AO, et al. Among authors: andersen mh. Eur J Immunol. 2004 Nov;34(11):3285-90. doi: 10.1002/eji.200324618. Eur J Immunol. 2004. PMID: 15384049 Free article.
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma.
Becker JC, Andersen MH, Hofmeister-Müller V, Wobser M, Frey L, Sandig C, Walter S, Singh-Jasuja H, Kämpgen E, Opitz A, Zapatka M, Bröcker EB, Thor Straten P, Schrama D, Ugurel S. Becker JC, et al. Among authors: andersen mh. Cancer Immunol Immunother. 2012 Nov;61(11):2091-103. doi: 10.1007/s00262-012-1266-9. Epub 2012 May 8. Cancer Immunol Immunother. 2012. PMID: 22565484 Free PMC article. Clinical Trial.
Shift from systemic to site-specific memory by tumor-targeted IL-2.
Schrama D, Xiang R, Eggert AO, Andersen MH, Pedersen Ls LØ, Kämpgen E, Schumacher TN, Reisfeld RR, Becker JC. Schrama D, et al. Among authors: andersen mh. J Immunol. 2004 May 15;172(10):5843-50. doi: 10.4049/jimmunol.172.10.5843. J Immunol. 2004. PMID: 15128763
379 results